Correlates Of Change in Cd4 Count Among the HIV Patients at Antiretroviral Treatment Centers in India: Cross Sectional Analysis of Secondary Data

Authors

  • Ram C Bajpai Nayati Healthcare and Research Pvt Ltd, Gurgaon
  • Himanshu K Chaturvdi2 National Institute of Medical Statistics, New Delhi
  • Nidhi Bhatnagar Army College of Medical Sciences, New Delhi
  • Ugra M Jha National AIDS Control Organization, New Delhi

Keywords:

CD4 count, HIV/AIDS, ART, Secondary data, Regression analysis, India

Abstract

Introduction: The CD4 count supervision is an important part of the HIV-care programme worldwide. The monitoring of CD4 counts over time could provide insight into the way patient’s respond to the treatment with effectiveness over time.

Methodology: Information on demographic and programme variables was extracted from 114210 patients across the country registered during 2007 with initial CD4 counts and longitudinally reassessed in 2012. The logistic regression method was used to find the factors associated with CD4 change either positive or negative.

Results: The CD4 counts increased significantly over time in different subcategories of age, sex, ART status and time to ART initiation. 50.7% of total registered HIV-patients exhibits any change in their CD4 from initial measurement. The regression analysis showed any change in CD4 was associated with age, TS/TG group, on ART patients and ART initiation after 1 year. Further, 75% of these patients were displayed increase in CD4 counts. The likelihood of increase in CD4 was statistically associated with higher chances within the subgroup of factors as age <15 years, TS/TG group and on ART patients.

Conclusion: Strategic interventions to increase early diagnosis of HIV infection, linkage to HIV-care and rapid access to ART must be implemented at country level, especially among the key population with poor access to HIV services.

References

World AIDS Day Report. UNAIDS, Geneva, Switzerland, 2012.

Technical reports:India HIV estimates.National AIDS Control Organization. Ministry of Health & Family Welfare, India, 2010.

Egger, M., May, M., and Chene, G., et al., 2002, Prognosis of HIV-I infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, Lancet, 360,119-129.

Mocroft, A., Vella, S., and Benfield, T.L., et al., 1998, Changing patterns of mortality across European patients infected with HIV-I, EuroSIDA Study Group, Lancet, 352, 1725-1730.

Annual reports: 2011-12. National AIDS Control Organization, Ministry of Health & Family Welfare, India, 2012.

Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, Tanuma J, Ng OT et al. Trend of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients. Jour Int AIDS Society 2014, 17:18808.

Smith CJ, Sabin CA, Youle MS, Loes SK, Lampe FC, Cropley I et al. Factors Influencing Increases in CD4 Cell Counts of HIV-Positive Persons Receiving Long-Term Highly Active Antiretroviral Therapy. JID 2004:190;1860-68.

Adams M, Luguterah A. Longitudinal analysis of change in CD4+ cell counts of HIV-1 patients on antiretroviral therapy (ART) in the Builsa district hospital. Eur Scientific Jour, 2013: 9:299-309.

Diggle, P. J., Heagerty, P. J., Liang, K.Y. and Zeger, S. L. (2002). Analysis of Longitudinal Data. 2nd ed. Oxford: Oxford University Press.

European AIDS Clinical Society. The European Guidelines for treatment of HIV infected adults in Europe [Internet]. Version 7.0-October 2013. Available from: http://www.eacsociety.org/Portals/0/Guidelines_Online_131014.pdf.

Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, et al. Antiretroviral treatment of adult HIV infec-tion: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308:387_402.

Sungkanuparph S, Techasathit W, Utaipiboon C, Chasombat S, Bhakeecheep S, Leechawengwongs M, et al. Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010. Asian Biomed. 2010;4:515-28.

World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection [Internet]. Available from: http://www.who.int /hiv/pub/guidelines/arv2013/en/

Adams M, Luguterah A. Growth dynamics of CD4 cells in HIV-1 patients on antiretroviral therapy (ART) at the Builsa district hospital in Ghana. American Jour Med Biological Res, 2013;1:138-144.

Rodriguez, W. R., Christodoulides N, Floriano, P. N, Gra-ham S, Mohanty S, , Meredith D, Trevor P, Shabnam Z, Ibou T, Dwight R, Bruce B, Adrian P G, Bruce D, John T M (2005) A Microchip CD4 Counting Method for HIV Monitoring in Resource-Poor Settings. PLoS Med 2(7): e182.

Hendriks JCM, Satten GA, Longini IM, et al. Use of immunological markers and continuous-time Markov model to estimate progression to HIV infection in homosexual men. AIDS 1996; 10: 649-56.

Taylor JMG, Cumberland WG, Sy JP. A stochastic model for the analysis of longitudinal AIDS data. J Am Stat Ass. 1994; 89: 727-36.

Kulkarni, H., Jason, F., Greg, G., Nancy, F., Michael, L., Braden, H., Glenn, W., Edmund T., Michael, P., Matthew, D., Alan, R., Brian, K., Sunil, K. and Vincent, C. Early post-seroconversion CD4+ cell counts independently predict CD4+ cell count recovery in HIV-1-postive subjects receiving antiretroviral therapy. J Acquir Immune Defic Syndr 2011;57:387–395.

Xiuhong, L., Margolick, J. B, Jamieson ,B. D., Rinaldo, C. R., John, P. Phair, J. P and Lisa, P. Jacobson, L. P. CD4+ T-Cell Counts and Plasma HIV-1 RNA Levels Beyond 5 Years of Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr 2011;57:421–428.

Hosmer DW, Lemeshow S: Applied logistic regression. New York: John Wiley & Sons; 2000.

The Natural History Project Working Group. Factors associated with short-term changes in HIV viral load and CD4+ cell count in antiretroviral-naive individuals. AIDS, 2014 (Accepted).

Hunt K, Konrad S, Mondal P, Gartner K, Skinner S, Lim JHJ. An investigation of social and clinical factors influencing trents in CD4 count among HIV-infected patients in Saskatoon, Canada. J Epidemiol Community Halth, 2013:67.

Zhou J, Sirisanthana T, Kiertiburanakul S, Chen YMA, Han N, Lim PL et al. Trend in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from the TREAT Asia HIV observational database. BMC Infectious Diseases, 2010; 10:361.

Wright ST, Petoumenos K, Boyd M, Carr A, Downing S, O’Connor CC et al. Ageing and long-term CD4 cell count trend in HIV-positive patients with 5 years or more combination antiretroviral therapy experience.

Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, Okamura M, Alvim MF, Fernandes R, et al. Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS One. 2012;7:e37125.

Downloads

Published

2016-02-29

How to Cite

1.
Bajpai RC, Chaturvdi2 HK, Bhatnagar N, Jha UM. Correlates Of Change in Cd4 Count Among the HIV Patients at Antiretroviral Treatment Centers in India: Cross Sectional Analysis of Secondary Data. Natl J Community Med [Internet]. 2016 Feb. 29 [cited 2024 Dec. 22];7(02):71-7. Available from: https://njcmindia.com/index.php/file/article/view/861

Issue

Section

Original Research Articles